Your session is about to expire
← Back to Search
Mobile Enhanced Prevention Support for HIV Prevention (MEPS Trial)
MEPS Trial Summary
This trial will provide HIV prevention and related support services to men who have sex with men and transgender women with substance abuse disorders who are leaving or have recently left jail. They will compare the utilization of services between those who receive routine case management and those who have access to a GPS-based mobile app, incentives, and peer mentor support.
MEPS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMEPS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MEPS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not own a smartphone and am not willing to get one.I am between 18 and 49 years old.I have had sex with a male or a male-to-female transgender woman in the last six months.I have never been diagnosed with HIV.
- Group 1: Standard of Care
- Group 2: Mobile Enhanced Prevention Support
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the aims of this clinical investigation?
"The primary analysis of this 9-month trial will focus on the number of participants that receive a Prep prescription from their primary care provider. Secondary categories comprise self-reported data regarding follow-up for HIV, STD and hepatitis c infections (n=200), an exploration of geographically based service utilization patterns among MEPS intervention arm participants via GeoPassport mobile app (n=100) and recidivism rate comparison between both arms (n=200)."
Is this experiment currently available to participants?
"Affirmative. According to the information presented on clinicaltrials.gov, this medical study is still looking for participants. It was initially posted in November 2019 and updated as recently as November 2022; 200 patients must be enrolled from 3 different locations."
To whom is enrollment in this clinical experiment open?
"This clinical trial is reaching out to 200 individuals between the ages of 18-49 who have been diagnosed with hepatitis c. The following criteria must also be met: if currently incarcerated, they are likely to remain in custody for at least four days but no longer than three months; housed in K6G unit or within 12 months post release from jail; has sought treatment and/or screened positive for Substance Use Disorder (SUD) during last twelve months before incarceration till present day; reported sexual intercourse with male or a transgender woman six months prior to being jailed; intends on residing in Los Angeles County for 12 consecutive months after enrollment into this study"
Does this investigation accept participants of thirty years or above?
"Justified by the inclusion criteria, this trial is only open to individuals aged 18-49. However, there are 200 and 690 additional trials available for youth and elderly participants respectively."
To what extent are participants engaged in this medical research?
"Affirmatively, clinicaltrials.gov provides evidence that this medical trial is currently enrolling participants. The experiment was initially posted on November 14th 2019 and revised recently in November 18th 2022. This research requires the recruitment of 200 volunteers at 3 different sites."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger